Boston Scientific (NYSE:BSX) today announced it received FDA approval for its Vercise Neural Navigator with StimView XT. The Marlborough, Massachusetts–based company designed its latest image-guided programming software in collaboration with Brainlab AG. It enables clinicians in real-time to visualize lead placement and stimulation modeling of the brain anatomy of patients with Parkinson’s disease or essential […]
Neuromodulation/Neurostimulation
Catheter delivery could enable better brain implants: Synchron’s neuroscience chief explains how
Synchron’s catheter delivery could make brain-computer interface technology simpler, safer and more accessible than the leading alternative: open-brain surgery. Officials at Synchron — developer of the catheter-delivered Stentrode brain-computer interface (BCI) implant — believe they’re the only BCI company tapping into blood vessels to capture signals from the brain. They say they’ve already enabled a […]
Battelle, Spark Biomedical partner on opioid use disorder detection, treatment
Battelle announced today that it entered into a collaborative agreement with Spark Biomedical to jointly run a pilot clinical study. Through the joint study, the two companies aim to advance the remote detection and treatment of opioid use disorder (OUD) using wearable biosensors. According to a news release, the study’s primary objective is to collect […]
Study produces ‘promising results’ for Carthera’s SonoCloud tech for mild Alzheimer’s symptoms
Carthera announced positive results from a trial evaluating the safety and efficacy of the use of its SonoCloud technology. Results from the investigator-sponsored trial of SonoCloud in patients with mild Alzheimer’s Disease (AD) were published this week in the Alzheimer’s Research & Therapy Journal. Paris-based Carthera designed SonoCloud, an implantable 1 MHz ultrasound device, to be […]
Cala Health announces new chief commercial, financial officers amid leadership expansion
Cala Health announced today that it has expanded its leadership team with a number of appointments, including new chief commercial and financial officers. New executives joining the company — which develops bioelectronic medicines to provide new therapies for chronic diseases — hold experience from major players in the medtech space, including iRhythm, Johnson & Johnson, […]
Medtronic completes first patient implants in implantable tibial neuromodulation trial
Medtronic (NYSE:MDT) announced that it completed the first patient implants in the Titan 2 pivotal study of its investigational neuromodulation device. Fridley, Minnesota-based Medtronic’s Titan 2 trial will evaluate the safety and efficacy of the company’s implantable tibial neuromodulation (TNM) device in people with overactive bladder (OAB). The company designed the minimally invasive implantable TNM […]
Medtronic survey says pandemic has negatively impacted those with chronic back and leg pain
Medtronic (NYSE:MDT) today released data from a survey demonstrating several struggles for those with chronic pain during the COVID-19 pandemic. The survey, commissioned by Medtronic and conducted by public opinion research firm The Harris Poll, found that 44% of current chronic back and leg pain sufferers experienced care delays during the COVID-19 pandemic despite 87% […]
FDA clears Cionic’s Neural Sleeve for mobility issues
Cionic announced today that it received FDA clearance for its leg-worn Cionic Neural Sleeve that provides functional electrical stimulation. San Francisco-based Cionic designed its lightweight Cionic Neural Sleeve to assist in gait for people with foot drop and leg muscle weakness, including those with mobility issues due to multiple sclerosis (MS), stroke, cerebral palsy (CP) […]
FDA clears Axonics’ recharge-free sacral neuromodulation system
Axonics Modulation Technologies (Nasdaq:AXNX) announced today that it received FDA approval for its new implantable neurostimulator. Irvine, California–based Axonics designed the Axonics F15 recharge-free sacral-neuromodulation (SNM) system with a functional life span of over 15 years at typical stimulation parameters and more than 2 decades at lower-energy settings. The system’s size totals 10 cubic centimeters, […]
Axonics ticks up on Street-beating Q4, expects recharge-free SNM launch in Q2
Axonics Modulation Technologies (NSDQ:AXNX) shares rose today on fourth-quarter results that beat the consensus forecast on Wall Street. The Irvine, California-based sacral neuromodulation (SNM) technology developer posted losses of $15.2 million, or 34¢ per share, on sales of $53.1 million for the three months ended Dec. 31, 2021, for a bottom-line of nearly $4 million […]
LivaNova implants first patient in Osprey obstructive sleep apnea study
LivaNova (NSDQ:LIVN) announced that it completed the first patient implant in a study of its LivaNova aura6000 system. London-based LivaNova designed the aura6000 system to maintain muscle tone of the tongue and upper airway so that airway obstruction and resulting sleep apnea are significantly reduced or eliminated. The hypoglossal neurostimulator system includes a programmable, rechargeable […]
